Bronchiolitis Recovery and the Use of High Efficiency Particulate Air (HEPA) Filters

NACompletedINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

November 7, 2022

Primary Completion Date

July 5, 2024

Study Completion Date

July 19, 2024

Conditions
Bronchiolitis
Interventions
OTHER

Winix 5500-2 HEPA filtration units

To determine if use of a HEPA filtration unit home intervention reduces the respiratory symptom burden (symptom-free days; SFD) for 24 weeks compared to a use of a control unit.

Trial Locations (17)

26506

West Virginia University, Morgantown

29203

Prisma Health-Midlands, Columbia

39216

University of Miss. Medical Center, Jackson

40292

University of Louisville, Louisville

57108

Avera Research Institute, Sioux Falls

59812

University of Montana, Missoula

66160

Kansas University Medical Center, Kansas City

68198

University of Nebraska Medical Center, Omaha

70112

Tulane University, Department of Pediatrics, New Orleans

72202

Arkansas Children's Hospital - Little Rock (ACHRI), Little Rock

73104

Children's Hospital OU Medical Center, Oklahoma City

87131

University of New Mexico Health Sciences Center, Albuquerque

96826

Kapi'olani Medical Center for Women and Children, Honolulu

99508

Alaska Native Tribal Health Consortium, Anchorage

03756

Dartmouth Hospital, Lebanon

02903

Rhode Island Hospital, Providence

05401

University of Vermont Medical Center, Burlington

All Listed Sponsors
collaborator

University of Vermont Medical Center

OTHER

collaborator

University of Montana

OTHER

collaborator

National Institutes of Health (NIH)

NIH

lead

IDeA States Pediatric Clinical Trials Network

NETWORK